Product Information
ABILIFY ASIMTUFII 960 MG/3.2 ML is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $1783.7497 per ML under NDC 59148011480. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Apr 27, 2023.
The High Outlier badge above means this manufacturer's average price in the Aripiprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
960 mg/3.2mL
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148011480
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA217006FDA Approved
4/27/2023
On Market Since
4/27/2023
Pharmacological Classes
Price Statistics
The NADAC for ABILIFY ASIMTUFII 960 MG/3.2 ML has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1783.7497 per ML |
|---|---|
| All-time high | $1786.7967 (Jun 10, 2026) |
| All-time low | $1673.5265 (Aug 21, 2024) |
| 52-week high | $1786.7967 |
| 52-week low | $1729.4462 |
| Median price | $1730.9569 |
| Average price | $1728.5034 |
| Largest weekly change | +3.0% (Jan 8, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Aripiprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ABILIFY ASIMTUFII 960 MG/3.2 ML?
The current National Average Drug Acquisition Cost (NADAC) for ABILIFY ASIMTUFII 960 MG/3.2 ML, manufactured by Otsuka America Pharmaceutical Inc., is $1783.7497 per ML (NDC 59148011480), effective Aug 19, 2026.
How has the price of ABILIFY ASIMTUFII 960 MG/3.2 ML changed over time?
Over the history we have for it, the NADAC for ABILIFY ASIMTUFII 960 MG/3.2 ML has risen 6.2%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ABILIFY ASIMTUFII 960 MG/3.2 ML?
Since Apr 17, 2024, the NADAC for ABILIFY ASIMTUFII 960 MG/3.2 ML has ranged from a low of $1673.5265 (Aug 21, 2024) to a high of $1786.7967 (Jun 10, 2026), with a median of $1730.9569 per ML.
Are there cheaper alternatives to ABILIFY ASIMTUFII 960 MG/3.2 ML?
No other NADAC-published product currently shares the active ingredient and strength of ABILIFY ASIMTUFII 960 MG/3.2 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ABILIFY ASIMTUFII 960 MG/3.2 ML?
ABILIFY ASIMTUFII 960 MG/3.2 ML (NDC 59148011480) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.